Agilent Technologies, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Agilent Technologies announced a 10% increase in net revenue for the second quarter of fiscal year 2026, driven by broad-based growth across all segments and geographic regions.
NYSE
Agilent Technologies reports a 7% increase in Q1 net revenue to $1.798 billion, driven by growth across all segments and regions, despite a 4% decline in net income to $305 million.
NYSE
Agilent Technologies reports strong third-quarter revenue growth of 10% and a 19% increase in net income, driven by its Life Sciences and Diagnostics Markets segment, despite ongoing restructuring costs and tariff impacts.
NYSE
Agilent Technologies reported a 6% increase in net revenue for the three months ended April 30, 2025, reaching $1.668 billion, but saw a significant 30% decline in net income to $215 million, impacted by higher operating costs and restructuring expenses.
NYSE
Agilent Technologies' first quarter 2025 results show a slight increase in revenue but a decrease in net income compared to the same period last year, driven by currency headwinds and changes in segment performance.
NYSE
Agilent Technologies' Q3 2024 results show a decrease in revenue and an increase in net income, alongside ongoing restructuring efforts and a new acquisition.
NYSE
Agilent Technologies' second-quarter results show a revenue decline due to decreased product sales, partially offset by growth in services, while net income saw a slight increase.
NYSE
Agilent Technologies' first quarter revenue decreased by 6% year-over-year, impacted by reduced customer spending and macroeconomic pressures, particularly in China.